Search results
Exact Sciences' (EXAS) BLUE-C Study Results Published in NEJM
Zacks via Yahoo Finance· 1 month agoExact Sciences Corporation EXAS recently announced the online publication of the BLUE-C study...
Colorectal Cancer Screening: How to Properly Take a Stool Sample
Health via Yahoo News· 5 months agoMore than 10% of fecal immunochemical tests (FIT) have unusable samples putting people at risk for...
Sorry, but Blood Tests Won’t Replace Stool Samples or Colonoscopies Yet
The Wall Street Journal· 3 weeks agoHEARD ON THE STREET For years now, there has been immense excitement for liquid biopsies—blood tests...
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 months agoExact Sciences Corp showcases robust revenue growth, reaching $2.50 billion in 2023, marking a 20%...
Analyst Report: Exact Sciences Corporation
Morningstar Research via Yahoo Finance· 13 hours agoExact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening ...
Guardant posts data for colon cancer blood test amid push from rivals
MedTech Dive via Yahoo Finance· 1 month agoDive Brief: Guardant Health shared clinical data on its colorectal cancer screening blood test in...
Cathie Wood Darling Exact Sciences, And Rival Guardant Health, Dip On Colon Cancer Updates
Investor's Business Daily· 1 month agoShares of Guardant Health and Exact Sciences skidded early Thursday after the companies unveiled...
Dreading your colonoscopy? New tests give consumers more options and require less prep
USA TODAY via Yahoo News· 4 months agoAn estimated 52,500 Americans died last year from colon cancer, yet the disease is highly treatable...
A Silicon Valley biotech just showed a simple blood test can detect a hidden and deadly type of...
Business Insider via Yahoo News· 1 year agoA standard blood draw.Hollis Johnson/Business Insider Guardant Health said that its blood test to...
Freenome’s colorectal cancer blood test data underwhelm analysts
MedTech Dive via Yahoo Finance· 3 weeks agoDive Brief: Freenome published topline results this week from a study of its blood-based test for...
